EU Delegation to the US: U.S. and EU Actions on Antimicrobial Resistance

Event information
Start:
End:
Venue:Webinar

The Miami-Florida Jean Monnet Center of Excellence would like to share this upcoming webinar organized by the Delegation of the European Union to the USA and the Infectious Disease Society of America.

Image

U.S. and EU Actions on Antimicrobial Resistance
A Transatlantic Dialogue on Public Health

_________________________________________________________________________________________

► To register, click here
_________________________________________________________________________________________

About this event

Antimicrobial resistance – the ability of microorganisms to resist antimicrobial treatments, especially antibiotics – has a direct impact on human and animal health. In the European Union alone, AMR is responsible for an estimated 33,000 deaths and $1.75 billion in health care costs each year.

To combat AMR the European Union has adopted a range of new measures including increased investments in antimicrobials, improving awareness of antimicrobial resistance by healthcare professionals and citizens alike, and working to cut overall sales of antimicrobials for farmed animals and aquaculture in half by 2030.

Join the European Union and the Infectious Disease Society of America as we examine priorities of the global antimicrobial resistance agenda. Hear from the top infectious disease officials in Europe and the United States and leading doctors on the frontline of tackling this challenge as we discuss how we can advance medical research to get in front of this threat.

Opening Remarks

  • Claire Bury, EU Deputy Director General for Health and Food Safety
  • Loyce Pace, US Department of Health and Human Services, Assistant Secretary of Global Affairs
  • Tiemo Wölken, Member of European Parliament
  • Sen. Michael Bennet (Colorado)
  • Rep. Chellie Pingree (Maine)
  • Michael Curtis, Deputy Ambassador of the European Union to the U.S.

Panel Discussion

  • Larry Kerr, US Department of Health and Human Services, Director of the Office of Pandemic and Emerging Threats
  • John Ryan, EU Director of Public Health
  • Anthony So, Johns Hopkins Bloomberg School of Public Health Professor of the Practice
  • Reshma Ramachandran, National Clinician Scholar, Yale University School of Medicine
  • Amanda Jezek, Infectious Diseases Society of America, Senior Vice President of Public Policy (moderator)

Closing Remarks

  • Claire Bury, EU Deputy Director General for Health and Food Safety
    U.S. and EU Actions on Antimicrobial Resistance


    Image